# FDA recall D-0044-2025

> **Cipla USA, Inc.** · Class II · drug recall initiated 2024-10-23.

## Product

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90

## Reason for recall

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

## Distribution

USA nationwide.

## Key facts

- **Recall number:** D-0044-2025
- **Recalling firm:** Cipla USA, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-10-23
- **Report date:** 2024-11-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Warren, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0044-2025

## Citation

> AI Analytics. FDA recall D-0044-2025. Retrieved 2026-06-12 from https://api.ai-analytics.org/recall/D-0044-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*